Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
US7807379B2 · kind B2 · utility
2Cited by
4References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2006 |
| Grant date | Oct 5, 2010 |
| Priority date | — |
| Expiry date | Jun 9, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/96494
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention describes a method for determining whether an individual is likely to suffer from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.